Pheiron
The AI engine Fit Assessment
BetaPheiron leverages machine learning to discover patterns and develop targeted therapeutics, while also focusing on biomarker identification for personalized medicine.
Blurb
Pheiron offers a data-driven platform for health management, enhancing drug development with AI and causal insights.
HQ Location
Berlin (Germany)
Founded
2023
Employees
1 - 10
Total funding raised
$4.22M
Funding Status
Venture - Series Unknown, $4.22M, June 20, 2025
Subspaces
- Biomarker Identification
We radically improve the probability of success in drug development by getting right what really matters: human evidence to back the target and prognostic disease signatures to define the population.